Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Mineralocorticoid receptors, both when in tissue extracts and when recombinant-derived, have equal affinity for the physiological mineralocorticoid aldosterone and for the glucocorticoids cortisol and corticosterone, which circulate at much higher concentrations than aldosterone. Such receptors are found in physiological mineralocorticoid target tissues (kidney, parotid, and colon) and in nontarget tissues such as hippocampus and heart. In mineralocorticoid target tissues the receptors are selective for aldosterone in vivo because of the presence of the enzyme 11 β-hydroxy-steroid dehydrogenase, which converts cortisol and corticosterone, but not aldosterone, to their 11-keto analogs. These analogs cannot bind to mineralocorticoid receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In mineralocorticoid-responsive tissues such as the kidney, cortisol is enzymatically converted to cortisone, a metabolically inactive steroid (569).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, the type 2 enzyme inactivates the mineralocorticoid activity of cortisol in the kidney tubule (569), and inactivating mutations in the type 2 enzyme cause a syndrome of apparent mineralocorticoid excess (AME) (588).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“Thus, 11HSD2 prevents cortisol from overwhelming renal mineralocorticoid receptors (569), and in the placenta and other fetal tissues 11HSD2 (583, 584) also inactivates cortisol.”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [569]
In the citing paper
“The kidney has high levels of HSD11B2 activity which protects the mineralocorticoid receptor from activation by cortisol by inactivating it to cortisone (Edwards and Stewart, 1991, Funder et al., 1988).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Funder et al., 1988
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Krozowski, Z. S., & Funder, J. W. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.6056 · Cited by 523
Self-citationThe Roles of Plasma Binding and Receptor Specificity in the Mineralocorticoid Action of Aldosterone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-994 · Cited by 232
Self-citationCharacterization of Rat Brain Aldosterone Receptors Reveals High Affinity for Corticosterone
BEAUMONT, K., & FANESTIL, D. D. (1983) · Endocrinology · doi:10.1210/endo-113-6-2043 · Cited by 193
Pearson Murphy, B. E. (1981) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(81)90226-0 · Cited by 178
Glucocorticoid Receptors in Rat Kidney: The Rinding of Tritiated-Dexamethasone1
FUNDER, J. W., FELDMAN, D., & EDELMAN, I. S. (1973) · Endocrinology · doi:10.1210/endo-92-4-1005 · Cited by 173
Self-citationAFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
Armanini, D., Karbowiak, I., & Funder, J. W. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00038.x · Cited by 163
Self-citationGlucocorticoid and mineralocorticoid receptors for aldosterone
Rousseau, G. G., Baxter, J. D., Funder, J. W., Edelman, I. S., & Tomkins, G. M. (1972) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(72)90053-2 · Cited by 151
Self-citation
Research works printed but not linked: 4
- Krozowski, Z. S., Proceedings of the National Academy of Sciences of the United States of America 80: 6056 (1983).
- SHEPPARD, K, MINERALOCORTICOID SPECIFICITY OF RENAL TYPE-I RECEPTORS - INVIVO BINDING-STUDIES, AMERICAN JOURNAL OF PHYSIOLOGY 252: E224 (1987).
- SHEPPARD, K, TYPE-I RECEPTORS IN PAROTID, COLON, AND PITUITARY ARE ALDOSTERONE SELECTIVE INVIVO, AMERICAN JOURNAL OF PHYSIOLOGY 253: E467 (1987).
- STEWART, P.M., CORTICOSTEROIDS PEPT 39: 163 (1987).
Cited by
Items 401–500 of 1,001
Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis
Young, M. J., & Rickard, A. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.008 · Cited by 77
Regulation of macrophage dehydroepiandrosterone sulfate metabolism by inflammatory cytokines
Hennebold, J. D. (1994) · Endocrinology · doi:10.1210/en.135.1.67 · Cited by 67
DHEA Induces 11β-HSD2 by Acting on CCAAT/Enhancer-Binding Proteins
Balazs, Z., Schweizer, R. A. S., Frey, F. J., Rohner-Jeanrenaud, F. C., & Odermatt, A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007030263 · Cited by 72
17β-Hydroxysteroid Dehydrogenase Type XI Localizes to Human Steroidogenic Cells
Chai, Z., Brereton, P., Suzuki, T., Sasano, H., Obeyesekere, V., Escher, G., Saffery, R., Fuller, P., Enriquez, C., & Krozowski, Z. (2003) · Endocrinology · doi:10.1210/en.2002-221030 · Cited by 64
A direct relationship between plasma aldosterone and cardiac L‐type Ca2+ current in mice
Perrier, R., Richard, S., Sainte–Marie, Y., Rossier, B. C., Jaisser, F., Hümmler, E., & Bénitah, J. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.092692 · Cited by 76
“Indeed, MRs have similar affinity for glucocorticoids and aldosterone (Arriza et al. 1987; Funder et al. 1988).”
BackgroundInfluentialThe cellular action of aldosterone in target epithelia
Bastl, C. P., & Hayslett, J. P. (1992) · Kidney International · doi:10.1038/ki.1992.284 · Cited by 76
Apparent mineralocorticoid excess
Wilson, R. C., Nimkarn, S., & New, M. I. (2001) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00356-8 · Cited by 75
Genomic and rapid effects of aldosterone: what we know and do not know thus far
Hermidorff, M. M., de Assis, L. V. M., & Isoldi, M. C. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9591-2 · Cited by 75
LISTER, K., Autelitano, D. J., Jenkins, A. J., Hannan, R. D., & Sheppard, K. E. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.010 · Cited by 75
“The enzyme 11h-hydroxysteroid dehydrogenase 2 (11hHSD2) converts endogenous glucocorticoids to receptor inactive 11-ketometabolites and in doing so enables aldosterone to access MR in vivo where glucocorticoid concentrations are 2–3 orders of magnitude higher [7,8].”
Glycyrrhizic acid: the assessment of a no effect level
van Gelderen, C. E. M., Bijlsma, J. A., Dokkum, W. V., & Savelkoull, T. J. F. (2000) · Human & Experimental Toxicology · doi:10.1191/096032700682694251 · Cited by 75
Immunolocalization of NAD-dependent 11β-hydroxysteroid dehydrogenase in human kidney and colon
Kyossev, Z. N., Walker, P. D., & Reeves, W. B. (1996) · Kidney International · doi:10.1038/ki.1996.39 · Cited by 75
Non-classical receptors for aldosterone in plasma membranes from pig kidneys
Christ, M., Sippel, K., Eisen, C., & Wehling, M. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90027-2 · Cited by 75
Fuller, P. J., Yang, J., & Young, M. J. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0060 · Cited by 74
Adipose Tissue and Adrenal Glands: Novel Pathophysiological Mechanisms and Clinical Applications
Kargi, A. Y., & Iacobellis, G. (2014) · International Journal of Endocrinology · doi:10.1155/2014/614074 · Cited by 74
“Adipocytes do not exhibit significant 11HSD2 activity, allowing glucocorticoids (GC), which circulate at 10-to-100-fold higher concentrations than mineralocorticoids (MC), to be the main ligand for adipocyte-MR [16].”
BackgroundIt takes two to tango: Dimerisation of glucocorticoid receptor and its anti-inflammatory functions
Nixon, M., Andrew, R., & Chapman, K. E. (2012) · Steroids · doi:10.1016/j.steroids.2012.09.013 · Cited by 74
Cloning, sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA
Rajan, V., Chapman, K. E., Lyons, V., Jamieson, P. M., Mullins, J. J., Edwards, C. R. W., & Seckl, J. R. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)00159-j · Cited by 74
Modulation of Human Mineralocorticoid Receptor Function by Protein Kinase A
Massaad, C. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.57 · Cited by 72
Structural Determinants of Aldosterone Binding Selectivity in the Mineralocorticoid Receptor
Rogerson, F. M., Dimopoulos, N., Sluka, P., Chu, S., Curtis, A. J., & Fuller, P. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36305 · Cited by 66
Pearce, D., Manis, A. D., Nesterov, V., & Korbmacher, C. (2022) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-022-02732-5 · Cited by 73
About Stress Hormones and Resilience to Psychopathology
De Kloet, E. R. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01707.x · Cited by 59
“Curiously, this MR was initially rather erroneously named the classical GR back in the 1970s because it bound B. It was subsequently demonstrated that MR in epithelial cells, such as those in the kidney, appeared aldosterone selective because of inactivation of B or Fb y 11b-hydroxysteroid dehydrogenase; this metaboli…”
BackgroundEnvironmental Pollutants and Hydroxysteroid Dehydrogenases
Ye, L., Guo, J., & Ge, R. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800095-3.00013-4 · Cited by 73
Aldosterone-sensitive HSD2 neurons in mice
Gasparini, S., Resch, J. M., Narayan, S. V., Peltekian, L., Iverson, G. N., Karthik, S., & Geerling, J. C. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1778-y · Cited by 73
Kato, H., Kanaoka, M., Yano, S., & Kobayashi, M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.6.1929 · Cited by 73
Jamieson, P., Nyirenda, M., Walker, B., Chapman, K., & Seckl (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1600103 · Cited by 66
“11âHSD-2 is an exclusive 11â-dehydrogenase (Rusvai & Náray-Fejes-Tóth 1993) conferring aldosterone selectivity on intrinsically non-specific mineralocorticoid receptors by rapidly inactivating glucocorticoids (Edwards et al. 1988, Funder et al. 1988).”
BackgroundMineralocorticoid receptor knockout mice: Lessons on Na+ metabolism
Berger, S., Bleich, M., Schmid, W., Greger, R. F., & Schütz, G. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00965.x · Cited by 73
Qian, Y., Deng, C., & Song, W.-C. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37617-7 · Cited by 68
“This concept was demonstrated adequately by the expression and activity of 11b-hydroxysteroid dehydrogenase in the kidney (Funder et al., 1988) and the 5a-reductase in the prostate (Roy, 1992).”
Fuller, P. J., & Verity, K. (1990) · Endocrinology · doi:10.1210/endo-127-1-32 · Cited by 73
Friese, R. S., Mahboubi, P., Mahapatra, N. R., Mahata, S. K., Schork, N. J., Schmid‐Schönbein, G. W., & OCONNOR, D. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.11.037 · Cited by 72
Genistein and other isoflavones found in soybeans inhibit estrogen metabolism in salmonid fish
Ng, Y., Hanson, S., Malison, J. A., Wentworth, B. C., & Barry, T. P. (2005) · Aquaculture · doi:10.1016/j.aquaculture.2005.10.039 · Cited by 72
A Switch in the Mechanism of Hypertension in the Syndrome of Apparent Mineralocorticoid Excess
Bailey, M. A., Paterson, J. M., Hadoke, P. W. F., Wrobel, N., Bellamy, C. O. C., Brownstein, D. G., Seckl, J. R., & Mullins, J. J. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007040401 · Cited by 66
Effect of licorice on the reduction of body fat mass in healthy subjects
Armanini, D., Palo, C. B. D., Mattarello, M. J., Spinella, P., Zaccaria, M., Ermolao, A., Palermo, M., Fiore, C., Sartorato, P., Francini‐Pesenti, F., et al. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347023 · Cited by 72
Mineralocorticoid selectivity: Molecular and cellular aspects
Farman, N., & Bocchi, B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00976.x · Cited by 71
Licorice and enzymes other than 11β-hydroxysteroid dehydrogenase: An evolutionary perspective
Baker, M. E. (1994) · Steroids · doi:10.1016/0039-128x(94)90091-4 · Cited by 71
Mutagenesis of the glucocorticoid receptor in mice
Kellendonk, C., Tronche, F., Reichardt, H. M., & Schütz, G. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00041-2 · Cited by 71
Looking beyond the dogma of genomic steroid action: insights and facts of the 1990s
Wehling, M. (1995) · Journal of Molecular Medicine · doi:10.1007/bf00202262 · Cited by 72
“The existence of specificity-conferring mechanisms such as the enzyme protection of type I receptors by 1 ll]-hydroxysteroid dehydrogenase [57, 58 ] has been implied by clinical observations and would be supplemented by those new findings on nongenomic mineralocorticoid effects described here.”
Disorders of Potassium Homeostasis: An Approach Based on Pathophysiology
Kamel, K. S., Quaggin, S. E., Scheich, A. M., & Halperin, M. L. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80220-4 · Cited by 70
Baserga, M., Hale, M. A., Wang, Z. M., Yu, X., Callaway, C. W., McKnight, R. A., & Lane, R. H. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00558.2006 · Cited by 70
Dean, M., Murphy, B. T., & Burdette, J. E. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.013 · Cited by 70
“…high affinity for the MR (Krozowski and Funder, 1983), 250 and 11-β-hydroxysteroid dehydrogenase (11βHSD, which inactivates cortisol) is required to keep 251 cortisol levels low enough in the kidney as to not activate the MR (Diederich et al., 2000; 252 Edwards et al., 1988; Funder et al., 1988).”
BackgroundAldosterone Modulates Steroid Receptor Binding to the Endothelin-1 Gene (edn1)
Stow, L. R., Gumz, M. L., Lynch, I. J., Greenlee, M. M., Rudin, A., Cain, B. D., & Wingo, C. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030718 · Cited by 69
Neuroendocrine Regulation of Hydromineral Homeostasis
Mecawi, A. S., Ruginsk, S. G., Elias, L. L. K., Varanda, W. A., & Antunes‐Rodrigues, J. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140031 · Cited by 69
Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye.
Rauz, S., Walker, E. A., Shackleton, C. H. L., Hewison, M., Murray, P. I., & Stewart, P. M. (2001) · PubMed · Cited by 69
Localization of Cortisol Receptor in Branchial Chloride Cells in Chum Salmon Fry
Uchida, K., Kaneko, T., Tagawa, M., & Hirano, T. (1998) · General and Comparative Endocrinology · doi:10.1006/gcen.1997.7019 · Cited by 69
Reduced activity of 11β-hydroxysteroid dehydrogenase in patients with cholestasis
Quattropani, C., Vogt, B., Odermatt, A., Dick, B., Frey, B. M., & Frey, F. J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12745 · Cited by 66
“One patient was receiving furosemide (40 mg/day), a diuretic known to inhibit human 11β-HSD2 activity (1).”
BackgroundInfluentialDaskalakis, N. P., Meijer, O. C., & de Kloet, E. R. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100455 · Cited by 57
“A similar conclusion on the role of 11HSD-2 in conferring aldosterone specificity was around the same time reached by John Funder (Funder et al., 1988).”
Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
Muñoz‐Durango, N., Vecchiola, A., González-Gómez, L. M., Simón, F., Riedel, C. A., Fardella, C., & Kalergis, A. M. (2015) · BioMed Research International · doi:10.1155/2015/652738 · Cited by 68
“The main cellular mechanism of regulation is the expression 11-𝛽-hydroxysteroid-dehydrogenase type 2 (11𝛽-HSD2), an enzyme capable of catalyzing the transformation of cortisol into inactive cortisone, reducing the probability of GCs to occupy available MRs [47, 48].”
BackgroundShibata, S. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0669 · Cited by 68
Glucocorticoids and gut bacteria: “The GALF Hypothesis” in the metagenomic era
Morris, D. J., & Ridlon, J. M. (2017) · Steroids · doi:10.1016/j.steroids.2017.06.002 · Cited by 68
Glucocorticoid action and the development of selective glucocorticoid receptor ligands
Cole, T. J. (2006) · Biotechnology annual review · doi:10.1016/s1387-2656(06)12008-6 · Cited by 68
Pre-receptor regulation of the androgen receptor
Penning, T. M., Jin, Y., Rižner, T. L., & Bauman, D. R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.10.008 · Cited by 68
“This pre-receptor regulation for steroid hormone action was first documented with the type 2 and type 1 11β-hydroxysteroid dehydrogenases (HSDs) (Funder et al., 1988; Whorwood and Stewart, 1996; White, 2001), Figure 1.”
BackgroundMethodde Kloet, E. R., Oitzl, M. S., & Schöbitz, B. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90002-7 · Cited by 68
Endogenous Glucocorticoids and Bone
Zhou, H., Cooper, M. S., & Seibel, M. J. (2013) · Bone Research · doi:10.4248/br201302001 · Cited by 67
Characterization of human mineralocorticosteroid receptor expressed in the baculovirus system.
Binart, N., Lombes, M., Rafestin-Oblin, M. E., & Baulieu, E. E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10681 · Cited by 51
Effects of steroid hormones on vascular functions
Suzuki, T., Nakamura, Y., Moriya, T., & Sasano, H. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10246 · Cited by 68
“11 -HSD type 2 is generally colocalized with MR in various human mineralocorticoid target tissues, where it confers mineralocorticoid specificity by protecting the nonselective MR from occupation by cortisol (Funder et al., 1988).”
BackgroundPenning, T. M. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00038-2 · Cited by 62
Rae, M., Mohamad, A., Price, D., Hadoke, P. W. F., Walker, B. R., Mason, J. I., Hillier, S. G., & Critchley, H. O. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1879 · Cited by 57
Aldosterone and the heart: towards a physiological function?
Delcayre, C., & Silvestre, J. S. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00088-7 · Cited by 67
Structural and molecular determinants of mineralocorticoid receptor signalling
Großmann, C., Almeida‐Prieto, B., Nolze, A., & de la Rosa, D. Á. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15746 · Cited by 66
“HSD1 is a bidirectional NADPH-dependent enzyme, and HSD2 is a NAD+-dependent glucocorticoid-inactivating enzyme (Chapman et al., 2013; Edwards et al., 1988; Funder et al., 1988).”
BackgroundEvolution of ligand specificity in vertebrate corticosteroid receptors
Arterbery, A. S., Fergus, D. J., Fogarty, E. A., Mayberry, J. K., Deitcher, D. L., Kraus, W. L., & Bass, A. H. (2011) · BMC Evolutionary Biology · doi:10.1186/1471-2148-11-14 · Cited by 66
“[see: [38]]. This reflects both the overall promiscuity of the MR and conserved sensitivity of the ancestral corticosteroid receptor (Table 2). Three of these steroids (DOC, 11-deoxycortisol, and cortisol) are present in the plasma of teleosts [39]; thus, teleost MR has either a wide array of endogenous ligands or alt…”
BackgroundAldosterone and mineralocorticoid receptors: Clinical studies and basic biology
Funder, J. W., & Mihailidou, A. S. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.029 · Cited by 66
Self-citationIdentification of a splice variant of the rat and human mineralocorticoid receptor genes
Bloem, L. J., Guo, C., & Pratt, J. H. (1995) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(95)00162-s · Cited by 66
Role of SGK in mineralocorticoid-regulated sodium transport
Pearce, D., Verrey, F., Chen, S.-Y., Mastroberardino, L., Meijer, O. C., Wang, J., & Bhargava, A. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00963.x · Cited by 66
Le Menuet, D., Viengchareun, S., Penfornis, P., Walker, F., Zennaro, M.-C., & Lombès, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7878 · Cited by 54
Ge, R., Dong, Q. G., Sottas, C. M., Latif, S. A., Morris, D. J., & Hardy, M. P. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.08.004 · Cited by 65
Evolution of Glucocorticoid and Mineralocorticoid Responses: Go Fish
Baker, M. E. (2003) · Endocrinology · doi:10.1210/en.2003-0843 · Cited by 65
Naray-Fejes-Toth, A. (1995) · Endocrinology · doi:10.1210/en.136.6.2579 · Cited by 61
Husted, R. F., Laplace, J. R., & Stokes, J. B. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114736 · Cited by 65
Brand, E., Kato, N., Chatelain, N., Krozowski, Z. S., Jeunemaître, X., Corvol, P. L., Plouin, P., Cambien, F., Pascoe, L., & Soubrier, F. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816110-00009 · Cited by 66
Wu, I., Shin, S. C., Cao, Y., Bender, I. K., Jafari, N., Feng, G., Lin, S., Cidlowski, J. A., Schleimer, R. P., & Lu, N. Z. (2013) · Cell Death & Disease · doi:10.1038/cddis.2012.193 · Cited by 64
Arthritis and the role of endogenous glucocorticoids
Macfarlane, E., Seibel, M. J., & Zhou, H. (2020) · Bone Research · doi:10.1038/s41413-020-00112-2 · Cited by 64
Baker, M. E. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.08.023 · Cited by 57
Role of Aldosterone in Renal Fibrosis
Shrestha, A., Che, R., & Zhang, A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8871-2_15 · Cited by 64
Liang, M., Yuan, B., Rute, E., Greene, A. S., Olivier, M., & Cowley, A. W. (2003) · Physiological Genomics · doi:10.1152/physiolgenomics.00089.2002 · Cited by 64
“Cortisol is a potent stimulator of mineralocorticoid receptors located in the distal nephron (7), leading to sodium retention.”
BackgroundClinical Use of Laboratory Tests for the Identification of Secondary Forms of Arterial Hypertension
Rossi, G. P., Seccia, T. M., & Pessina, A. C. (2006) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360600931831 · Cited by 64
Lavery, G. G., Ronconi, V., Draper, N., Rabbitt, E. H., Lyons, V., Chapman, K. E., Walker, E. A., McTernan, C. L., Giacchetti, G., Mantero, F., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000083340.57063.35 · Cited by 64
Funder, J. W. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90074-s · Cited by 64
Self-citationBidirectional activity of 11β-hydroxysteroid dehydrogenase in vascular smooth muscle cells
Brem, A. S., Bina, R. B., King, T. C., & Morris, D. J. (1995) · Steroids · doi:10.1016/0039-128x(94)00074-m · Cited by 64
Minireview: Regulation of Gene Expression by Nuclear Hormone Receptors
Meier, C. A. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709036612 · Cited by 64
Interactions of the mineralocorticoid receptor – Within and without
Yang, J., & Fuller, P. J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.001 · Cited by 63
Cheng, L., Poulsen, S. B., Wu, Q., Esteva-Font, C., Olesen, E. T. B., Peng, L., Olde, B., Leeb-Lundberg, L. M. F., Pisitkun, T., Rieg, T., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018101025 · Cited by 59
Henschkowski, J., Stuck, A. E., Frey, B. M., Gillmann, G., Dick, B., Frey, F. J., & Mohaupt, M. G. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.152 · Cited by 58
Mineralocorticoid receptor ligands: Biochemical, pharmacological, and clinical aspects
Sutanto, W., & de Kloet, E. R. (1991) · Medicinal Research Reviews · doi:10.1002/med.2610110604 · Cited by 63
30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations
Zennaro, M., & Fernandes-Rosa, F. L. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0089 · Cited by 62
“…into the inactive metabolites cortisone and 11-dehydrocorticosterone, thus modulating intracellular glucocorticoid levels and protecting the nonselective MR from occupation by glucocorticoids (Edwards et al. 1988, Funder et al. 1988 for a detailed review, see the article by Funder in this issue).”
BackgroundNuclear receptors in podocyte biology and glomerular disease
Agrawal, S., He, C., & Tharaux, P. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00339-6 · Cited by 62
Hypoxia causes down‐regulation of 11β‐hydroxysteroid dehydrogenase type 2 by induction of Egr‐1
Heiniger, C. D., Kostadinova, R. M., Rochat, M. K., Serra, A. L., Ferrari, P., Dick, B., Frey, B. M., & Frey, F. J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0582fje · Cited by 62
“The overall corticosteroid hormone action of glucocorticoids depends on their secretion rate, metabolism, local access to the cognate receptor, and responsiveness of the target cells when the receptors are activated (1, 41, 59).”
BackgroundGennari, F. J. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.06.004 · Cited by 62
Further studies on the mechanism of the mineralocorticoid action of licorice in humans
Armanini, D., Lewicka, S., Pratesi, C., Scali, M., Zennaro, M., Zovato, S., Gottardo, C., Simoncini, M., Spigariol, A., & Zampollo, V. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03349029 · Cited by 62
Ferrari, P., Obeyesekere, V. R., Li, K., Wilson, R. C., New, M. I., Funder, J. W., & Krozowski, Z. S. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03787-2 · Cited by 62
Self-citationGenomic epidemiology of blood pressure salt sensitivity
Kelly, T. N., & He, J. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283524949 · Cited by 61
Rose’Meyer, R. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-37 · Cited by 55
Ignatova, I. D., Kostadinova, R. M., Goldring, C. E., Nawrocki, A. R., Frey, F. J., & Frey, B. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90531.2008 · Cited by 61
Stewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Driver, P. M. (2001) · Molecular Human Reproduction · doi:10.1093/molehr/7.4.357 · Cited by 55
“© European Society of Human Reproduction and Embryology 357 enabling aldosterone to bind to the receptor in vivo (Edwards et al., 1988; Funder et al., 1988).”
Reinhardt, T. A., & Horst, R. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71566-4 · Cited by 61
Detection of glycyrrhetinic acid-like factors (GALFs) in human urine.
Morris, D. J., Semafuko, W. E., Latif, S. A., Vogel, B., Grimes, C. A., & Sheff, M. F. (1992) · Hypertension · doi:10.1161/01.hyp.20.3.356 · Cited by 61
Evidence for distinct isoforms of 11β-hydroxysteroid dehydrogenase in the ovine liver and kidney
Yang, K., & Yu, M. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90016-7 · Cited by 61
Feraco, A., Armani, A., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.012 · Cited by 60
Impact of Adrenal Steroids on Regulation of Adipose Tissue
Infante, M., Armani, A., Mammi, C., Fabbri, A., & Caprio, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160037 · Cited by 60
Mineralocorticoid receptor gene expression in the gastrointestinal tract: Distribution and ontogeny
Fuller, P. J., & Verity, K. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90215-e · Cited by 60
Mineralocorticoid Receptors and Hormones: Fishing for Answers
Gilmour, K. M. (2004) · Endocrinology · doi:10.1210/en.2004-1390 · Cited by 60
Quinkler, M., Zehnder, D., Lepenies, J., Petrelli, M. D., Moore, J. S., Hughes, S. V., Cockwell, P., Hewison, M., & Stewart, P. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01954 · Cited by 51
“In the human kidney, 11b-HSD2 is expressed in cortical and medullary collecting ducts (22) as well as in the glomerulus (28), and is responsible for the conversion of cortisol to hormonally inactive cortisone thus conferring the in vivo specificity of the MR for aldosterone (5, 6 ).”
Background
Metadata
- Authors
- Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I.
- Affiliations
- Medical Research Centre, Prince Henry's Hospital, Melbourne, Australia 3004.
- Venue
- Science
- Published
- 1988-10-28
- Volume
- 242
- Issue
- 4878
- Pages
- 583-585
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2148114970
- Semantic Scholar
- ae47dabb539e84fc85ea0bfd3f1a669037f37264
- Cited by
- 1,628
- References
- 19
- Citations by year
- 2026: 15 · 2025: 7 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 25 · 2019: 32 · 2018: 32 · 2017: 33 · 2016: 26 · 2015: 30 · 2014: 37 · 2013: 44 · 2012: 56
- FWCI
- 30.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- mineralocorticoid receptor, aldosterone, glucocorticoids, cortisol, corticosterone, 11β-hydroxysteroid dehydrogenase, 11-keto steroids, kidney, parotid gland, colon, hippocampus, heart
- MeSH terms
- Adrenalectomy, Aldosterone, Animals, Carbenoxolone, Colon, Corticosterone, Heart, Hippocampus, Hydrocortisone, Hydroxysteroid Dehydrogenases, Kidney, Parotid Gland, Receptors, Steroid, Receptors, Mineralocorticoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.